Invuity’s patented Intelligent Photonics™ devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
Second Quarter Revenue Increased 69 Percent Over Prior Year Period SAN FRANCISCO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a medical technology company, today reported financial results for the second quarter and six-months ended June 30, 2015. Q2 2015 Highlights Revenue grew 69 percent to $4.7 million compared to revenue of $2.8 million in the 2014 second quarter. Revenue would have been $5.0 million, without the impact of a $300,000 adjustment. Invuity sold its devices to approximately 450 hospitals in the second quarter of 2015. In June 2015, Invuity closed its initial public offering (IPO) of 4,600,000 shares of common stock (including...Read More
SAN FRANCISCO, Aug. 10, 2015 /PRNewswire/ -- Invuity, Inc. (NASDAQ:IVTY), a medical technology company, today announced the appointment of medical device financial and operations executive James H. Mackaness as its Chief Financial Officer, effective August 24th. Mackaness will report directly to President and CEO Philip Sawyer. Mackaness brings more than 20 years of experience as a senior financial executive to Invuity, having worked for both public and private companies in the Bay Area. His wide-ranging expertise includes financial and strategic planning, public reporting and controls, mergers and acquisitions, and operations management within the medical device and technology industries...Read More
SAN FRANCISCO, July 28, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that it will release its 2015 second quarter and six-month financial results after the market closes on Tuesday, August 11, 2015. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Tuesday, August 11, 2015, to discuss the financial results and other business developments. Interested parties may access the live call via telephone by dialing 1-855-539-0900 (U.S.) or 1-412-455-6044 (International). To listen to the live call via Invuity's website, go to www.invuity.com, in the Even...Read More
“I operate with greater efficiency and surgical precision because I can direct the light where I need it – the light follows me instead of me following the light. I have reduced my surgical time by an average of 15% and experience less operative blood loss. This challenging surgical approach is now easier, quicker and safer when using the Saber with Yankauer – it makes my life easier.”
Joint Replacement Surgery with Specialty in Anterior Approach Hip Replacement and Pelvic/Acetabular Trauma Surgery
Southeast Hospital and St. Francis Medical Center
Cape Girardeau, MO
“This is revolutionary technology that will change the way we do minimally invasive breast surgery. It is simply must have instrumentation to work more confident, and efficient in delicate anatomy.”
Anne Arundel Medical Center
“The Saber Waveguide with Yankauer is one of the most significant technological advancements in orthopedic surgery this year. I’m excited to begin using it in my total hip replacement, oncology and orthopedic trauma surgeries.”
UAB Medical Center